ImmunoPrecise Antibodies Ltd. (IPA)

NASDAQ: IPA · Real-Time Price · USD

0.400

-0.020 (-4.74%)

At close: Dec 20, 2024, 4:00 PM

0.410

+0.010 (2.42%)

After-hours: Dec 20, 2024, 4:55 PM EST

ImmunoPrecise Antibodies Market Cap

ImmunoPrecise Antibodies has a market cap or net worth of $13.42 million as of December 20, 2024. Its market cap has decreased by -54.60% in one year.

Market Cap

13.42M

Enterprise Value

22.67M

1-Year Change

-54.60%

Ranking

#5003

Market Cap Chart

Since January 19, 2017, ImmunoPrecise Antibodies's market cap has decreased from $32.77M to $13.42M, a decrease of -59.06%. That is a compound annual growth rate of -10.66%.

Market Cap History

Date	Market Cap	% Change
Dec 20, 2024	13.42M	-70.19%
Dec 29, 2023	45.00M	-65.36%
Dec 30, 2022	129.91M	24.75%
Dec 31, 2021	104.14M	-58.72%
Dec 31, 2020	252.30M	742.75%
Dec 31, 2019	29.94M	-12.68%
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
ProPhase Labs	15.59M
Minerva Neurosciences	14.97M
Innovative Eyewear	14.41M
Ekso Bionics Holdings	14.21M
BioXcel Therapeutics	13.48M
Streamline Health Solutions	13.44M
GlycoMimetics	13.25M
Kazia Therapeutics	13.20M

Market Cap Rankings